SONN Stock Earnings: Sonnet BioTherapeutics Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
SONN stock results show that Sonnet BioTherapeutics missed analyst estimates for earnings per share the second quarter of 2024.
The post SONN Stock Earnings: Sonnet BioTherapeutics Misses EPS for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace